Related Experiment Video
Updated: Jun 6, 2025

13:19
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.5K
Grade III rash induced by abemaciclib in a patient with HR+/HER-2 negative breast cancer
Yu Yao1, Zheng-Cai Zhu1, Tao Li1
1Department of Thyroid and Breast, The Affiliated Taizhou People's Hospital of Nanjing Medical University, China.
Asian Journal of Surgery
|November 30, 2024
Abstract
No abstract available in PubMed .
Keywords:
AbemaciclibBreast neoplasmsCyclin-dependent kinase inhibitorsDermatologic toxicitiesDrug eruptions
